Janus Henderson Group PLC Bridge Bio Pharma, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,312,531 shares of BBIO stock, worth $106 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,312,531
Previous 3,312,706
30.18%
Holding current value
$106 Million
Previous $102 Million
6.65%
% of portfolio
0.06%
Previous 0.06%
Shares
21 transactions
Others Institutions Holding BBIO
# of Institutions
305Shares Held
179MCall Options Held
8.68MPut Options Held
2.75M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$765 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$618 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$350 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$306 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$149 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.65B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...